| Abstrakt: |
Integrating Artificial Intelligence (AI) into Precision Medicine (PM) is redefining healthcare, enabling personalized treatments tailored to individual patients based on their genetic code, environment, and lifestyle. AI's ability to analyze vast and complex datasets, including genomics and medical records, facilitates the identification of hidden patterns and correlations, which are critical for developing personalized treatment plans. Unsupervised Learning (UL) is particularly valuable in PM as it can analyze unstructured and unlabeled data to uncover novel disease subtypes, biomarkers, and patient stratifications. By revealing patterns that are not explicitly labeled, unsupervised algorithms enable the discovery of new insights into disease mechanisms and patient variability, advancing our understanding of individual responses to treatment. However, the integration of AI into PM presents some challenges, including concerns about data privacy and the rigorous validation of AI models in clinical practice. Despite these challenges, AI holds immense potential to revolutionize PM, offering a more personalized, efficient, and effective approach to healthcare. Collaboration among AI developers and clinicians is essential to fully realize this potential and ensure ethical and reliable implementation in medical practice. This review will explore the latest emerging UL technologies in the biomedical field with a particular focus on PM applications and their impact on human health and well-being. [ABSTRACT FROM AUTHOR] |
